BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

185 related articles for article (PubMed ID: 36751253)

  • 1. Case Report and Literature Review of Cardiac Amyloidosis: A Not-So-Rare Cause of Heart Failure.
    Baptista P; Moura de Azevedo S; Alexandre A; Dias-Frias A
    Cureus; 2023 Jan; 15(1):e33364. PubMed ID: 36751253
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Beta 2-microglobulin: case report of a rare cause of cardiac amyloidosis.
    Haslett JJ; Patel JK; Kittleson MM
    Eur Heart J Case Rep; 2023 May; 7(5):ytad239. PubMed ID: 37223323
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Noninvasive Diagnostic Modalities in an Isolated Case of Cardiac Amyloidosis.
    Lewars J; Wazir H; Gordon B; Faluyi U; Girgis Y
    Cureus; 2021 Apr; 13(4):e14608. PubMed ID: 34040908
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A challenging road to diagnosing transthyretin cardiac amyloidosis and using technetium-99m pyrophosphate bone scintigraphy in nuclear cardiology - A case report.
    Kavita A; Abdul Onny MA; Suppiah S; Abdul Aziz AF; Hashim H; Raja Shariff RE; Ng CS
    Med J Malaysia; 2021 Sep; 76(5):762-767. PubMed ID: 34508392
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Transthyretin Cardiac Amyloidosis: An Evolution in Diagnosis and Management of an "Old" Disease.
    Smiley DA; Rodriguez CM; Maurer MS
    Cardiol Clin; 2022 Nov; 40(4):541-558. PubMed ID: 36210137
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Cardiac amyloidosis: State of art in 2022].
    Oghina S; Delbarre MA; Poullot E; Belhadj K; Fanen P; Damy T
    Rev Med Interne; 2022 Sep; 43(9):537-544. PubMed ID: 35870985
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cardiac Transthyretin Amyloidosis: Hidden in Plain Sight.
    Logothetis CN; Fernandez J; Laber DA
    Case Rep Med; 2021; 2021():2551964. PubMed ID: 34917152
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Multimodality Imaging for Diagnosing Transthyretin Cardiac Amyloidosis.
    Palot Manzil FF; Pandey T
    Cureus; 2023 Apr; 15(4):e37838. PubMed ID: 37214019
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hereditary cardiac amyloidosis associated with Pro24Ser transthyretin mutation: a case report.
    Yamamoto H; Hashimoto T; Kawamura S; Hiroe M; Yamashita T; Ando Y; Yokochi T
    J Med Case Rep; 2018 Dec; 12(1):370. PubMed ID: 30553273
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Transthyretin Cardiac Amyloidosis.
    Mankad AK; Shah KB
    Curr Cardiol Rep; 2017 Aug; 19(10):97. PubMed ID: 28840452
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The role of echocardiography and 99mTc-HDP scintigraphy in non-invasive diagnosis of cardiac amyloidosis: A case series and literature review.
    Costache II; Buburuz AM; Crisu D; Statescu AM; Ungureanu C; Aursulesei V
    Medicine (Baltimore); 2019 Sep; 98(38):e17256. PubMed ID: 31567998
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Transthyretin cardiac amyloidosis: an under-diagnosed cause of heart failure.
    Molina O G; Judge D; Campbell W; Chahal H; Mugmon M
    J Community Hosp Intern Med Perspect; 2014; 4(5):25500. PubMed ID: 25432650
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cardiac amyloidosis-An underdiagnosed cause of heart failure: A case report and review of literature.
    Parmar K; Benjanuwattra J; Sethi P; Tijani L; Hurst P; Pertuz GD; Argueta-Sosa E
    Clin Case Rep; 2022 Dec; 10(12):e6525. PubMed ID: 36478969
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cardiac Transthyretin-derived Amyloidosis: An Emerging Target in Heart Failure with Preserved Ejection Fraction?
    Klaassen SH; van Veldhuisen DJ; Nienhuis H; van den Berg MP; Hazenberg BP; van der Meer P
    Card Fail Rev; 2020 Mar; 6():e21. PubMed ID: 32944291
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Diagnostic imaging of cardiac amyloidosis.
    Martinez-Naharro A; Baksi AJ; Hawkins PN; Fontana M
    Nat Rev Cardiol; 2020 Jul; 17(7):413-426. PubMed ID: 32042139
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cardiac amyloidosis-an underdiagnosed cause of heart failure in the elderly.
    Nazir T; Nuffati M
    J Saudi Heart Assoc; 2020; 32(1):98-102. PubMed ID: 33154899
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cardiac Amyloidosis: Overlooked, Underappreciated, and Treatable.
    Rubin J; Maurer MS
    Annu Rev Med; 2020 Jan; 71():203-219. PubMed ID: 31986086
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Practical recommendations for the diagnosis and management of transthyretin cardiac amyloidosis.
    Bistola V; Parissis J; Foukarakis E; Valsamaki PN; Anastasakis A; Koutsis G; Efthimiadis G; Kastritis E
    Heart Fail Rev; 2021 Jul; 26(4):861-879. PubMed ID: 33452596
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical Phenotyping of Transthyretin Cardiac Amyloidosis with Bone-Seeking Radiotracers in Heart Failure with Preserved Ejection Fraction.
    Chen W; Ton VK; Dilsizian V
    Curr Cardiol Rep; 2018 Mar; 20(4):23. PubMed ID: 29520480
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Amyloid transthyretin cardiac amyloidosis: diagnosis and management.
    Di Giovanni B; Gustafson D; Delgado DH
    Expert Rev Cardiovasc Ther; 2019 Sep; 17(9):673-681. PubMed ID: 31478389
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.